Hyo-Jun Kim1, Jin-Haeng Lee1, Sung-Yup Cho1,2, Ju-Hong Jeon3,2, In-Gyu Kim4,5,6. 1. Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Korea. 2. Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea. 3. Institute of Human-Environment Interface Biology, Seoul National University College of Medicine, Seoul, Korea. 4. Department of Biochemistry and Molecular Biology, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul, 03080, Korea. igkim@plaza.snu.ac.kr. 5. Institute of Human-Environment Interface Biology, Seoul National University College of Medicine, Seoul, Korea. igkim@plaza.snu.ac.kr. 6. Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea. igkim@plaza.snu.ac.kr.
Abstract
BACKGROUND: Transglutaminase 2 (TG2) mediates protein modifications by crosslinking or by incorporating polyamine in response to oxidative or DNA-damaging stress, thereby regulating apoptosis, extracellular matrix formation, and inflammation. The regulation of transcriptional activity by TG2-mediated histone serotonylation or by Sp1 crosslinking may also contribute to cellular stress responses. OBJECTIVE: In this study, we attempted to identify TG2-interacting proteins to better understand the role of TG2 in transcriptional regulation. METHODS: Using a yeast two-hybrid assay to screen a HeLa cell cDNA library, we found that TG2 bound BAF250a, a core subunit of the cBAF chromatin remodeling complex, through an interaction between the TG2 barrel 1 and BAF250a C-terminal domains. RESULTS: TG2 was pulled down with a GST-BAF250a C-term fusion protein. Moreover, TG2 and BAF250a were co-fractionated using P11 chromatography, and co-immunoprecipitated. A transamidation reaction showed that TG2 mediated incorporation of polyamine into BAF250a. In glucocorticoid response-element reporter-expressing cells, TG2 overexpression increased the luciferase reporter activity in a transamidation-dependent manner. In addition, a comparison of genome-wide gene expression between wild-type and TG2-deficient primary hepatocytes in response to dexamethasone treatment showed that TG2 further enhanced or suppressed the expression of dexamethasone-regulated genes that were identified by a gene ontology enrichment analysis. CONCLUSION: Thus, our results indicate that TG2 regulates transcriptional activity through BAF250a polyamination.
BACKGROUND: Transglutaminase 2 (TG2) mediates protein modifications by crosslinking or by incorporating polyamine in response to oxidative or DNA-damaging stress, thereby regulating apoptosis, extracellular matrix formation, and inflammation. The regulation of transcriptional activity by TG2-mediated histone serotonylation or by Sp1 crosslinking may also contribute to cellular stress responses. OBJECTIVE: In this study, we attempted to identify TG2-interacting proteins to better understand the role of TG2 in transcriptional regulation. METHODS: Using a yeast two-hybrid assay to screen a HeLa cell cDNA library, we found that TG2 bound BAF250a, a core subunit of the cBAF chromatin remodeling complex, through an interaction between the TG2 barrel 1 and BAF250a C-terminal domains. RESULTS: TG2 was pulled down with a GST-BAF250a C-term fusion protein. Moreover, TG2 and BAF250a were co-fractionated using P11 chromatography, and co-immunoprecipitated. A transamidation reaction showed that TG2 mediated incorporation of polyamine into BAF250a. In glucocorticoid response-element reporter-expressing cells, TG2 overexpression increased the luciferase reporter activity in a transamidation-dependent manner. In addition, a comparison of genome-wide gene expression between wild-type and TG2-deficient primary hepatocytes in response to dexamethasone treatment showed that TG2 further enhanced or suppressed the expression of dexamethasone-regulated genes that were identified by a gene ontology enrichment analysis. CONCLUSION: Thus, our results indicate that TG2 regulates transcriptional activity through BAF250a polyamination.
Authors: Kihang Choi; Matthew Siegel; Justin L Piper; Liya Yuan; Eun Cho; Pavel Strnad; Bishr Omary; Keith M Rich; Chaitan Khosla Journal: Chem Biol Date: 2005-04
Authors: G-Y Jang; J-H Jeon; S-Y Cho; D-M Shin; C-W Kim; E M Jeong; H C Bae; T W Kim; S-H Lee; Y Choi; D-S Lee; S-C Park; I-G Kim Journal: Oncogene Date: 2009-10-19 Impact factor: 9.867
Authors: Lingbao Ai; Wan-Ju Kim; Berna Demircan; Lisa M Dyer; Kevin J Bray; Ryan R Skehan; Nicole A Massoll; Kevin D Brown Journal: Carcinogenesis Date: 2008-01-03 Impact factor: 4.944
Authors: Ju Hong Jeon; Chai Wan Kim; Dong Myung Shin; Kyu il Kim; Sung Yup Cho; Joon Cheol Kwon; Kyung Ho Choi; Heun Soo Kang; In Gyu Kim Journal: FEBS Lett Date: 2003-01-16 Impact factor: 4.124
Authors: Lorna A Farrelly; Robert E Thompson; Shuai Zhao; Ashley E Lepack; Yang Lyu; Natarajan V Bhanu; Baichao Zhang; Yong-Hwee E Loh; Aarthi Ramakrishnan; Krishna C Vadodaria; Kelly J Heard; Galina Erikson; Tomoyoshi Nakadai; Ryan M Bastle; Bradley J Lukasak; Henry Zebroski; Natalia Alenina; Michael Bader; Olivier Berton; Robert G Roeder; Henrik Molina; Fred H Gage; Li Shen; Benjamin A Garcia; Haitao Li; Tom W Muir; Ian Maze Journal: Nature Date: 2019-03-13 Impact factor: 49.962
Authors: Nazia Abbasi; Tianyun Long; Yuxin Li; Brian A Yee; Benjamin S Cho; Juan E Hernandez; Evelyn Ma; Parth R Patel; Debashis Sahoo; Ibrahim M Sayed; Nissi Varki; Soumita Das; Pradipta Ghosh; Gene W Yeo; Wendy Jia Men Huang Journal: Life Sci Alliance Date: 2020-08-18